Pachter et al., 2003 - Google Patents
The blood-brain barrier and its role in immune privilege in the central nervous systemPachter et al., 2003
View PDF- Document ID
- 18278001053164649641
- Author
- Pachter J
- de Vries H
- Fabry Z
- Publication year
- Publication venue
- Journal of Neuropathology & Experimental Neurology
External Links
Snippet
The blood-brain barrier (BBB) provides both anatomical and physiological protection for the central nervous system (CNS), strictly regulating the entry of many substances and blood borne cells into the nervous tissue. Increased understanding of how the unique …
- 210000001218 Blood-Brain Barrier 0 title abstract description 116
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pachter et al. | The blood-brain barrier and its role in immune privilege in the central nervous system | |
Nishihara et al. | Advancing human induced pluripotent stem cell‐derived blood‐brain barrier models for studying immune cell interactions | |
Lima et al. | Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages | |
Séguin et al. | Regulation and functional effects of monocyte migration across human brain-derived endothelial cells | |
Sonar et al. | IFN‐γ promotes transendothelial migration of CD4+ T cells across the blood–brain barrier | |
Muller | Migration of leukocytes across endothelial junctions: some concepts and controversies | |
Dardalhon et al. | CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions | |
Somersalo et al. | Cytotoxic T lymphocytes form an antigen-independent ring junction | |
Chizzolini et al. | Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis | |
Katakai et al. | Organizer-like reticular stromal cell layer common to adult secondary lymphoid organs | |
Barreiro et al. | Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation | |
Martín-Gayo et al. | Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development | |
Bryceson et al. | Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion | |
Ning et al. | Interactions between ICAM-5 and β1 integrins regulate neuronal synapse formation | |
Honda et al. | Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis | |
Watanabe et al. | Atherosclerosis and inflammation: Mononuclear cell recruitment and adhesion molecules with reference to the implication of ICAM-1/LFA-1 pathway in atherogenesis | |
Farrar et al. | An instructive component in T helper cell type 2 (Th2) development mediated by GATA-3 | |
Bahbouhi et al. | Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line | |
Real et al. | Immature dendritic cells (DCs) use chemokines and intercellular adhesion molecule (ICAM)-1, but not DC-specific ICAM-3-grabbing nonintegrin, to stimulate CD4+ T cells in the absence of exogenous antigen | |
Sun et al. | Encephalitogenic activity of truncated myelin oligodendrocyte glycoprotein (MOG) peptides and their recognition by CD8+ MOG‐specific T cells on oligomeric MHC class I molecules | |
Allam et al. | Developing T cells form an immunological synapse for passage through the β-selection checkpoint | |
Mendes-da-Cruz et al. | Multivectorial abnormal cell migration in the NOD mouse thymus | |
Mustjoki et al. | Intercellular adhesion molecule‐1 in extravasation of normal mononuclear and leukaemia cells | |
Fouillet et al. | CCL2 binding is CCR2 independent in primary adult human astrocytes | |
Roxanis et al. | True epithelial hyperplasia in the thymus of early-onset myasthenia gravis patients: implications for immunopathogenesis |